Long-term treatment with anakinra and canakinumab resolves patellar subchondral erosion in neonatal-onset multisystem inflammatory disease.
Adolescent
Antibodies, Monoclonal
/ therapeutic use
Antibodies, Monoclonal, Humanized
Antirheumatic Agents
/ therapeutic use
Bone Diseases, Developmental
/ diagnostic imaging
Cryopyrin-Associated Periodic Syndromes
/ drug therapy
Humans
Interleukin 1 Receptor Antagonist Protein
/ therapeutic use
Magnetic Resonance Imaging
Male
Patella
/ diagnostic imaging
Young Adult
Journal
Reumatismo
ISSN: 0048-7449
Titre abrégé: Reumatismo
Pays: Italy
ID NLM: 0401302
Informations de publication
Date de publication:
01 Apr 2019
01 Apr 2019
Historique:
received:
13
03
2018
accepted:
28
10
2018
entrez:
2
4
2019
pubmed:
2
4
2019
medline:
30
11
2019
Statut:
epublish
Résumé
Not available.
Identifiants
pubmed: 30932446
doi: 10.4081/reumatismo.2019.1142
doi:
Substances chimiques
Antibodies, Monoclonal
0
Antibodies, Monoclonal, Humanized
0
Antirheumatic Agents
0
Interleukin 1 Receptor Antagonist Protein
0
canakinumab
37CQ2C7X93
Types de publication
Case Reports
Letter
Langues
eng
Sous-ensembles de citation
IM